Lexicon Pharmaceuticals's total assets for Q4 2024 were $298.42M, a decrease of -7.07% from the previous quarter. LXRX total liabilities were $152.47M for the fiscal quarter, a 6.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.